# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 213: Amendment of regulation 281 (duties of authorisation holders and registration holders)

Extent: E+W+S+N.I.

In regulation 281(1)—
(a) in sub-paragraph (a), insert “ UK ” before “marketing authorisation”;
(b) omit “or” at the end of sub-paragraph (c); and
(c) in sub-paragraph (d), after “for a medicinal product” insert—
“; or
(e) an EU marketing authorisation for a medicinal product.”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/213 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-213
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.